Research and Development

Showing 10925 articles
Business

Beyond the Rally: Why PNC Financial's Momentum May Mask Deeper Concerns

Despite outperforming the S&P 500 by nearly 11% over the past six months, a closer look at PNC Financial Services Group reveals pressure on core banking metrics. Analysts point to tepid net interest income growth and a projected decline in tangible book value as reasons for caution, suggesting investors may find better opportunities elsewhere in the financial sector.

Business

Calavo's Post-Earnings Slump: A Value Trap or Turnaround Play?

Shares of avocado and fresh food distributor Calavo Growers (CVGW) have lagged the broader market, declining 4.2% over the past six months. Following its Q3 earnings, investors are weighing whether the stock's current valuation presents an opportunity or reflects deeper challenges in its business model.

Business

CytomX Therapeutics Surges on Promising Early Colorectal Cancer Data, Analysts Bullish on Probody Platform

Shares of CytomX Therapeutics (CTMX) jumped over 14% this week after early-stage clinical data for its lead Probody candidate, varsetatug maseatecan, in metastatic colorectal cancer drew positive reactions from Wall Street. The move highlights growing confidence in the company's conditionally activated antibody platform, designed to target tumors more precisely while sparing healthy tissue.